3Churchill D, Taylor D, Keshavia P. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes [J]. J Am Soc Nephrol, 1996,7 (2) : 198-207.
4Bargman JM,Thorpe KE,Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study[J]. J Am Soc Nephrol,2001,12(10) : 2158-2162.
5Tam P. Peritoneal dialysis and preservation of residual renal function[J]. Perit Dial Int,2009,29(Suppl 2):S108 Sll0.
6Marr6n B, Rem6n C, P4rez-Fontdn M, et al. Benefits of preserving residual renal function in peritoneal dialysis[J].Kidney Int Suppl, 2008, (108) : S42-S51.
7Perl J, Bargman JM. The importance of residual kidney function for patients on dialysis: a critical review[J]. Am J Kidney Dis,2009,53(6) : 1068-1081.
8Van der Wal WM,Noordzij M,Dekker FW,et al. Full loss of residual renal function causes higher mortality in dialysis patients: findings from a marginal structural model [J]. Nephrol Dial Transplant,2011,26(9) :2978-2983.
9Yang Q,Li R,Zhong Z,et al. Is cystatin C a better marker than creatinine for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis [J]. Nephrol Dial Transplant,2011(10) :3358- 3365.
9Locatelli F, Covic A, Chazot C, et al. Hypertension and cardiovascular risk assessment in dialysis patients[J]. Nephrol Dial Transplant,2004,19(5) : 1058-1068.
10Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease[J]. J Am Soc Nephrol, 1998,9(12 Suppl) :S31-S42.
